Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-05-27FDA Approved: LOXAPINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for LOXAPINE (loxapine) from Actavis Pharma, Inc.
-
FDA approval · 2009-05-27FDA Approved: LOXAPINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for LOXAPINE (loxapine) from Actavis Pharma, Inc., under ANDA072205. This action represents an appro…
-
FDA approval · 2009-05-22FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for trifluoperazine hydrochloride from Mylan Pharmaceuticals Inc., approving the generic product und…
-
FDA approval · 2009-05-22FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Fluphenazine Decanoate from Hikma Pharmaceuticals USA Inc. The action pertains to a supplemental…
-
FDA approval · 2009-05-06FDA Approved: FANAPT — Original Application (Vanda Pharmaceuticals Inc.)
FDA approved FANAPT (iloperidone) under the original application by Vanda Pharmaceuticals Inc. for the treatment of schizophrenia. This entr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-04-30FDA Approved: PERPHENAZINE — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for Perphenazine from Endo USA, Inc., resulting in an approved update to the product labeling.
-
FDA approval · 2009-04-30FDA Approved: RISPERIDONE — Original Application (Par Health USA, LLC)
FDA approves Par Health USA, LLC's original application for a generic risperidone product, expanding access to the standard indications for …
-
FDA approval · 2009-04-08FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Clozapine submitted by Mylan Pharmaceuticals Inc. The action confirms regulatory clearance f…
-
FDA approval · 2009-03-23FDA Approved: RISPERIDONE — Original Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved the original application for Risperidone from Jubilant Cadista Pharmaceuticals Inc., enabling generic risperidone to be markete…
-
FDA approval · 2009-03-14FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approves a supplemental application for haloperidol decanoate submitted by Fresenius Kabi USA, LLC.
-
FDA approval · 2009-03-12FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for Fluphenazine hydrochloride submitted by PAI Holdings, LLC dba PAI Pharma.
-
FDA approval · 2009-03-12FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
The FDA approved a supplemental application for fluphenazine hydrochloride (generic) from PAI Holdings, LLC dba PAI Pharma, indicating an ap…
-
FDA approval · 2009-02-24FDA Approved: RISPERIDONE — Original Application (Amici Pharma, Inc.)
FDA approves the original application for a risperidone generic from Amici Pharma, Inc.
-
FDA approval · 2009-01-30FDA Approved: RISPERIDONE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approves ANI Pharmaceuticals' original application for risperidone, adding a generic version of the antipsychotic.
-
FDA approval · 2009-01-29FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for HALOPERIDOL DECANOATE from Mylan Institutional LLC, a long-acting injectable antipsychotic used …
-
FDA approval · 2009-01-23FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA has approved a supplemental application for thioridazine hydrochloride from Mylan Pharmaceuticals, indicating a regulatory change to…
-
FDA approval · 2009-01-23FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for fluphenazine hydrochloride by Lannett, adding another generic version of this antipsychotic to t…
-
FDA approval · 2009-01-21FDA Approved: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for the generic combination product PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE from Mylan Pharmace…
-
FDA approval · 2008-11-25FDA Approved: PERPHENAZINE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for PERPHENAZINE submitted by Sandoz Inc.
-
FDA approval · 2008-11-25FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for trifluoperazine hydrochloride from Sandoz Inc., confirming an additional approval for this gener…
-
FDA approval · 2008-11-25FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for trifluoperazine hydrochloride from Sandoz Inc., a generic antipsychotic. The action confirms reg…
-
FDA approval · 2008-11-25FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for trifluoperazine hydrochloride from Sandoz Inc., updating the product’s status accordingly.
-
FDA approval · 2008-11-25FDA Approved: HALOPERIDOL — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for HALOPERIDOL (generic) from PAI Holdings, LLC dba PAI Pharma under ANDA073037.
-
FDA approval · 2008-11-19FDA Approved: PERPHENAZINE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for perphenazine submitted by Sandoz Inc to support continued marketing of the drug.
-
FDA approval · 2008-11-19FDA Approved: LOXAPINE — Supplemental Application (Elite Laboratories, Inc.)
FDA approved a supplemental application for LOXAPINE (loxapine) by Elite Laboratories, Inc. under ANDA076868, approving changes to the gener…